CoChat

Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases

Open access

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

BACKGROUND: To evaluate the characteristics of type 2 diabetes (T2DM) patients with or without chronic kidney disease (CKD) in Germany. METHODS: and albuminuria (≥ 30 mg/g). Median values of the most recent treatment year per patient are reported. RESULTS: and 51.2% had a urinary albumin level ≥ 30 mg/g. They were older, had a longer diabetes duration and a higher proportion was females compared to patients without CKD (all p < 0.001). More than half of CKD patients (53.5%) were receiving long-acting insulin-based therapy versus around 39.1% of those without (p < 0.001). CKD patients also had a higher rate of hypertension (79.4% vs 72.0%; p < 0.001). The most common antihypertensive drugs among CKD patients were renin-angiotensin-aldosteron system inhibitors (angiotensin converting enzyme inhibitors 33.8%, angiotensin receptor blockers 14.2%) and diuretics (40.2%). CKD patients had a higher rate of dyslipidemia (88.4% vs 86.3%) with higher triglyceride levels (157.9 vs 151.0 mg/dL) and lower HDL-C levels (men: 40.0 vs 42.0 mg/dL; women: 46.4 vs 50.0 mg/dL) (all p < 0.001) and a higher rate of hyperkalemia (> 5.5 mmol/L: 3.7% vs. 1.0%). Comorbidities were more common among CKD patients (p < 0.001). CONCLUSION: The results illustrate the prevalence and morbidity burden associated with diabetic kidney disease in patients with T2DM in Germany. The data call for more attention to the presence of chronic kidney disease in patients with diabetes, should trigger intensified risk factor control up and beyond the control of blood glucose and HbA1c in these patients. They may also serve as a trigger for future investigations into this patient population asking for new treatment options to be developed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12933-019-0837-x

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Patient flow chart. GFR glomerular filtration rate, MDRD modification of diet in renal disease formula, T2DM type 2 diabetes mellitus
Fig. 1 Patient flow chart. GFR glomerular filtration rate, MDRD modification of diet in renal disease formula, T2DM type 2 diabetes mellitusCC BY · PubMed Central
Fig. 2 Prevalence of chronic kidney disease by GFR and albuminuria (based on [22]). Green, low risk (if no other markers of kidney disease, no CKD); yellow, moderately increased risk; orange, high risk; red, very high risk. *240.510 patients with information on eGFR category and albuminuria, data are presented as absolute numbers (percent of 240.510). n = 103.165 with missing values on microalbuminuria and/or macroalbuminuria
Fig. 2 Prevalence of chronic kidney disease by GFR and albuminuria (based on [22]). Green, low risk (if no other markers of kidney disease, no CKD); yellow, moderately increased risk; orange, high risk; red, very high risk. *240.510 patients with information on eGFR category and albuminuria, data are presented as absolute numbers (percent of 240.510). n = 103.165 with missing values on microalbuminuria and/or macroalbuminuriaCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 70

Metadata

Authors
Bramlage, P., Lanzinger, S., van Mark, G., Hess, E., Fahrner, S., Heyer, C. H. J., Friebe, M., Seufert, J., Danne, T., & Holl, R. W.
Affiliations
  • IPPMed (Germany) (DE)
  • Universität Ulm (DE)
  • Evangelisches Krankenhaus Oberhausen (DE)
  • University of Freiburg (DE)
  • Kinderkrankenhaus auf der Bult (DE)
Corresponding author
Bramlage, Peter
Venue
Cardiovascular Diabetology
Published
2019-03-16
Volume
18
Issue
1
Pages
33-33
ISSN
1475-2840 (ISSN-L)
OpenAlex
W2920958092
Cited by
65
References
55
Citations by year
2026: 4 · 2025: 10 · 2024: 5 · 2023: 13 · 2022: 8 · 2021: 6 · 2020: 15 · 2019: 4
FWCI
6.37
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0/ (tdm)
Locations
  • Cardiovascular Diabetology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • European Foundation of Diabetes
  • German Diabetes Society
  • Sanofi
  • AstraZeneca
  • Bayer
  • Abbott
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 2 diabetes, chronic kidney disease, diabetic nephropathy, albuminuria, hypertension, dyslipidemia, hyperkalemia, long-acting insulin, renin-angiotensin-aldosterone system inhibitors, comorbidities, risk factor control
MeSH terms
Age Factors, Aged, Albuminuria, Angiotensin-Converting Enzyme Inhibitors, Austria, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Diuretics, Female, Germany, Glomerular Filtration Rate, Humans, Hypoglycemic Agents, Kidney, Luxembourg, Male, Middle Aged, Registries, Risk Factors, Sex Factors, Comorbidity, Prevalence, Databases, Factual, Risk Assessment, Renal Insufficiency, Chronic, Angiotensin Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases. https://app.cochat.ai/papers/10.1186/s12933-019-0837-x
The paper
Bramlage, P., Lanzinger, S., van Mark, G., Hess, E., Fahrner, S., Heyer, C. H. J., Friebe, M., Seufert, J., Danne, T., & Holl, R. W. (2019). Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-019-0837-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.